BDBM239474 US9416126, P6
BDBM104043 PDI inhibitor P6
BDBM301479 US10131673, Compound P6
BDBM428839 US20250092017, Compound P6
BDBM546506 US11291655, No P6
BDBM741299 US20250161476, P# P6
BDBM220399 US9296708, 5, ARM-P6
BDBM218988 US9303033, P6, Table 19A, Compound 15
1-benzoyl-4-[bis(4-fluorophenyl)methyl]piperazine BDBM25799 piperazine, p6
BDBM694502 c(y-(NHex-Gua-Hexin)a-R-Nal-G) US20240293587, Compound P6
US10513512, Compound P6 BDBM425971 5-hydroxy-2-(4-methoxyphenyl)-7-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)-propoxy)-chroman-4-one
US11465984, Example P6 2-(2-chloropyridin- 3-yl)-1-(7- fluoro-5-(2- ((tetrahydrofuran- 3-yl)amino) pyrimidin-4-yl) indolin-1-yl)ethan- 1-one BDBM575737
BDBM450646 US10676465, Example 23 1-(2-methoxyethyl)-2-{[4-(2-phenyl-1,3- benzodioxol-4-yl)piperazin-1-yl]methyl}- 1H-benzimidazole-6-carboxylic acid, ENT-X2, trifluoroacetate salt, [from P6]
- Kim, SE; Liu, F; Im, YJ; Stephen, AG; Fivash, MJ; Waheed, AA; Freed, EO; Fisher, RJ; Hurley, JH; Burke, TR Elucidation of New Binding Interactions with the Tumor Susceptibility Gene 101 (Tsg101) Protein Using Modified HIV-1 Gag-p6 Derived Peptide Ligands. ACS Med Chem Lett 2: 337-341 (2011)
- Cingolani, G; Panella, A; Perrone, MG; Vitale, P; Di Mauro, G; Fortuna, CG; Armen, RS; Ferorelli, S; Smith, WL; Scilimati, A Structural basis for selective inhibition of Cyclooxygenase-1 (COX-1) by diarylisoxazoles mofezolac and 3-(5-chlorofuran-2-yl)-5-methyl-4-phenylisoxazole (P6). Eur J Med Chem 138: 661-668 (2017)